Zacks Research Has Negative Estimate for TriMas Q1 Earnings

TriMas Corporation (NASDAQ:TRS) – Analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for shares of TriMas in a research report issued on Thursday, March 12th. Zacks Research analyst Team now forecasts that the industrial products company will earn $0.18 per share for the quarter, down from their prior estimate of $0.54. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q2 2026 earnings at $0.47 EPS, Q3 2026 earnings at $0.54 EPS, Q4 2026 earnings at $0.40 EPS, FY2026 earnings at $1.59 EPS, Q1 2027 earnings at $0.32 EPS, Q2 2027 earnings at $0.59 EPS, Q3 2027 earnings at $0.65 EPS, Q4 2027 earnings at $0.52 EPS and FY2027 earnings at $2.08 EPS.

A number of other research analysts have also issued reports on TRS. KeyCorp restated an “overweight” rating and issued a $38.00 target price on shares of TriMas in a report on Thursday, February 26th. Wall Street Zen downgraded shares of TriMas from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. BWS Financial reissued a “buy” rating and issued a $45.00 price objective on shares of TriMas in a research report on Monday, March 2nd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research note on Monday, December 29th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $41.50.

TriMas Trading Down 0.7%

TriMas stock opened at $35.04 on Monday. The stock has a market cap of $1.32 billion, a PE ratio of 11.80 and a beta of 0.54. The stock has a 50-day moving average price of $35.94 and a 200 day moving average price of $35.97. TriMas has a 52 week low of $19.45 and a 52 week high of $42.00. The company has a current ratio of 2.52, a quick ratio of 1.93 and a debt-to-equity ratio of 0.66.

TriMas (NASDAQ:TRS) last released its quarterly earnings results on Thursday, February 26th. The industrial products company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.01). TriMas had a return on equity of 12.04% and a net margin of 11.53%.The company had revenue of ($139.97) million during the quarter, compared to analyst estimates of $192.96 million. During the same period last year, the firm earned $0.43 earnings per share. The business’s revenue was up 12.4% compared to the same quarter last year.

Institutional Trading of TriMas

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of TriMas by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company’s stock worth $565,000 after acquiring an additional 1,014 shares during the period. Jane Street Group LLC purchased a new stake in TriMas in the first quarter valued at approximately $868,000. AE Wealth Management LLC purchased a new stake in TriMas in the second quarter valued at approximately $212,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in TriMas during the second quarter worth approximately $230,000. Finally, LSV Asset Management acquired a new position in TriMas during the second quarter worth approximately $498,000. Hedge funds and other institutional investors own 99.42% of the company’s stock.

TriMas Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 27th were given a dividend of $0.04 per share. The ex-dividend date was Friday, February 27th. This represents a $0.16 annualized dividend and a yield of 0.5%. TriMas’s dividend payout ratio is 5.39%.

TriMas News Roundup

Here are the key news stories impacting TriMas this week:

• Negative Sentiment: Zacks cut FY2026 estimates sharply to $1.59 EPS (from $2.50 previously) and lowered FY2027 to $2.08 EPS (from $2.54), flagging weaker outlook for the next two years. This broad downgrade to multi‑year EPS expectations is a negative catalyst for TRS. MarketBeat TRS
• Negative Sentiment: Zacks reduced Q1–Q4 2026 quarter estimates (Q1 2026 to $0.18 from $0.54; Q2 2026 to $0.47 from $0.73; Q3 2026 to $0.54 from $0.69; Q4 2026 to $0.40 from $0.54), signaling the firm expects weaker near‑term operating performance. MarketBeat TRS
• Negative Sentiment: Zacks lowered multiple 2027 quarterly forecasts (Q1 2027 to $0.32; Q2 2027 to $0.59; Q3 2027 to $0.65; Q4 2027 to $0.52), reflecting a downshift in expected growth/recovery that pushes FY2027 estimate down. MarketBeat TRS
• Negative Sentiment: Zacks maintains a “Strong Sell” rating on TRS — a sentiment signal that can pressure shares by encouraging selling or reduced appetite among risk‑sensitive investors. MarketBeat TRS
• Negative Sentiment: Zacks published an FY2028 earnings estimate note for TriMas (new multi‑year modeling), extending its downward revisions into longer‑term forecasts — an additional factor that could weigh on investor sentiment. FY2028 Earnings Estimate for TriMas Issued By Zacks Research

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.